IGF-1 LR3: The Anabolic Signal That Runs Past Its Brakes

IGF-1 LR3 is where the peptide world stops being mild. Most of the research peptides people run do subtle things — a percentage point of fat, a nudge of sleep quality, a faster tendon recovery. IGF-1 LR3 activates the Akt/mTOR pathway, which is the master switch for cell growth. When it works, it works. It also raises the stakes: hypoglycemia is real, non-selective growth promotion is real, and the people who run it casually usually stop running it casually.

This isn't a beginner's compound. Treat it accordingly.

What it is, in one paragraph

IGF-1 LR3 is an 83-amino-acid engineered variant of native IGF-1. The "LR3" describes two modifications: a 13-amino-acid N-terminal extension ("Long") and an arginine swap at position 3 ("R3"). Together they drop its affinity for IGF binding proteins (IGFBPs) by ~100-fold. Native IGF-1 is 95–99% bound in circulation, meaning only a sliver is bioactive. LR3 circulates free, and its half-life jumps from ~15 minutes to 20–30 hours. It hits the IGF-1 receptor with normal potency, but because it isn't sequestered, it signals harder and longer. It also retains low but meaningful insulin receptor cross-reactivity — that's your hypoglycemia vector.

Dosing: what people actually do

Sub-Q, once daily, with or after a meal to blunt hypoglycemia.

• Starting: 20 mcg once daily
• Standard: 40 mcg once daily
• High end: 50–60 mcg once daily
• Bilateral/local: some users split the dose and inject near trained muscle groups on training days

Cycles run 4 weeks on, 4 weeks off, and almost never more than 6–8 weeks continuous. Receptor desensitization is real; so is the broader concern about running an mTOR agonist indefinitely.

"First dose at 40 mcg without food — I was on the floor shaking 90 minutes later. Ate a banana, drank a juice, fine in 20 minutes. Second time I ate a protein+carb meal first, no problem. Don't skip that step. Ever." — forum user

What it pairs with

• Food, carbs, protein — not optional. Hypoglycemia is the #1 issue
• BPC-157 / TB-500 — the recovery stack people run during heavy training blocks
• MGF — more local-action IGF-1 splice variant; some users run it on training days and LR3 on off-days
• CJC-1295 / Ipamorelin — endogenous GH + exogenous IGF-1 is the "full GH axis" stack
• Follistatin in more aggressive muscle-building protocols
• Not stacked with insulin (that's a completely different risk level)

Red flags and side effects

• Hypoglycemia — the big one. Shakiness, sweating, hunger, mental fog, eventually worse. Manage with food around dosing
• Hunger spike — common, often dramatic in the hour post-injection
• Mild lethargy or brain fog — usually resolves after the first week
• Carpal tunnel / fluid retention — shows up at higher doses and longer runs, same as with GH
• Numbness/tingling — occasional, usually resolves
• Injection-site reactions — infrequent

The bigger concern is the one nobody can put a number on: IGF-1 signaling promotes cell proliferation broadly — muscle, fibroblasts, and cells you don't want proliferating. Chronic elevated IGF-1 is associated in epidemiological data with higher cancer risk. This is why the thoughtful users cycle hard and don't treat it as a long-term daily compound.

The honest limits

• No human clinical trials on LR3 specifically. Human IGF-1 data comes from mecasermin (native IGF-1) in IGF-1 deficiency populations. LR3 inherits that mechanism but not that safety data
• Non-selective growth. Anything with an IGF-1R gets the signal. That includes tissues you're not training
• Hypoglycemia is an actual injury vector. People have ended up in ERs from bad dosing. Food discipline isn't optional
• WADA-banned as a growth factor. Tested athletes shouldn't be reading this
• Product quality matters enormously. LR3 is a complex molecule with critical disulfide bonds. Bad product = denatured peptide that does nothing (best case) or signals weirdly (worst case). COA or don't

Where to go next

• For the full mechanism, the Akt/mTOR pathway breakdown, and the IGFBP biology, see the Pepperpedia IGF-1 LR3 entry.
• For training-block logs, dose-splitting strategies, and hypoglycemia management threads, the Protocol Discussions forum is where experienced users work it out.
• For reconstitution math on a 1 mg vial, PepperCalc handles it.
• Running a recovery stack? See BPC-157 and TB-500.